Author: Roche-Campo, F.; Aguirre-Bermeo, H.; Mancebo, J.
Title: Glucocorticoids in the treatment of acute respiratory distress syndrome Cord-id: hipvvezt Document date: 2011_10_25
ID: hipvvezt
Snippet: Acute respiratory distress syndrome (ARDS) is characterized by local inflammation and an intense systemic inflammatory reaction. Glucocorticoid administration has been suggested due to their anti-inflammatory properties. However, results from the initial studies of glucocorticoids in ARDS, which evaluated high-dose and short-term treatments, were negative. More recent studies have evaluated the effect of lower doses of glucocorticoids administered over longer periods, but the results thus far ha
Document: Acute respiratory distress syndrome (ARDS) is characterized by local inflammation and an intense systemic inflammatory reaction. Glucocorticoid administration has been suggested due to their anti-inflammatory properties. However, results from the initial studies of glucocorticoids in ARDS, which evaluated high-dose and short-term treatments, were negative. More recent studies have evaluated the effect of lower doses of glucocorticoids administered over longer periods, but the results thus far have been inconclusive.
Search related documents:
Co phrase search for related documents- abrupt discontinuation and acute illness: 1
Co phrase search for related documents, hyperlinks ordered by date